For procurement professionals and R&D scientists in the pharmaceutical industry, securing a consistent and high-quality supply of key intermediates is non-negotiable. Myxin, identified by CAS number 13925-12-7, is a notable pharmaceutical intermediate valued for its antibiotic, bacteriostatic, and antifungal properties. This article delves into the critical aspects of sourcing Myxin, emphasizing the importance of quality and supply chain reliability, especially when dealing with manufacturers and suppliers in China.

Myxin, also known by its chemical name 1-hydroxy-6-methoxyphenazine 5,10-dioxide, and as the 3C-Antibiotic, is a reddish, acicular crystal. Its specified melting point range of 120-130°C and its molecular formula (C13H10N2O4) are fundamental pieces of information for chemists. The compound's inherent biological activities make it a sought-after ingredient for developing new antimicrobial agents or for use in advanced research applications. When businesses decide to buy Myxin pharmaceutical intermediate, they are often looking for a partner who can deliver consistent purity and performance.

The global chemical market offers numerous options, but for specialized intermediates like Myxin, reliability is key. China has become a significant global player in chemical manufacturing, providing access to a wide range of compounds. Identifying a reputable Chinese manufacturer or supplier for Myxin is crucial. Such partners can offer competitive pricing and ensure a stable supply chain, which is vital for uninterrupted research and production schedules. A direct relationship with a manufacturer can also lead to better communication regarding product specifications, lead times, and potential customization needs.

For organizations that need to purchase Myxin regularly, establishing a robust supply chain is an ongoing priority. This involves not only negotiating favorable terms but also ensuring that the supplier adheres to strict quality control measures. Requesting detailed Certificates of Analysis (CoA) for each batch of Myxin is a standard practice to verify purity and confirm it meets the required specifications. The availability of Myxin for sale from well-vetted sources ensures that research projects can proceed without the risk of material inconsistencies that could invalidate results or delay development.

In conclusion, Myxin (CAS 13925-12-7) is a valuable pharmaceutical intermediate, and its reliable sourcing is critical for success in the pharmaceutical industry. By focusing on quality assurance, supply chain stability, and partnering with trustworthy manufacturers and suppliers, particularly those in China, companies can ensure they have consistent access to this important compound, thereby supporting innovation and development in antibiotic research and beyond.